{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:51:21Z","timestamp":1789015881913,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T00:00:00Z","timestamp":1590192000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.biopha.2020.110316","type":"journal-article","created":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T04:42:00Z","timestamp":1590813720000},"page":"110316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Analysis of the molecular mechanism of Pudilan (PDL) treatment for COVID-19 by network pharmacology tools"],"prefix":"10.1016","volume":"128","author":[{"given":"Qi","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuran","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2020.110316_bib0005","first-page":"4","article-title":"A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)","volume":"7","author":"Jin","year":"2020","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.biopha.2020.110316_bib0010","doi-asserted-by":"crossref","first-page":"104743","DOI":"10.1016\/j.phrs.2020.104743","article-title":"Traditional Chinese medicine for COVID-19 treatment","volume":"155","author":"Ren","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"10","key":"10.1016\/j.biopha.2020.110316_bib0015","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.7150\/ijbs.45538","article-title":"Traditional chinese medicine in the treatment of patients infected with 2019-New coronavirus (SARS-CoV-2): a review and perspective","volume":"16","author":"Yang","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.biopha.2020.110316_bib0020","doi-asserted-by":"crossref","first-page":"104882","DOI":"10.1016\/j.phrs.2020.104882","article-title":"The clinical benefits of Chinese patent medicines against COVID-19 based on current evidence","volume":"157","author":"Zhang","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"07","key":"10.1016\/j.biopha.2020.110316_bib0025","first-page":"1","article-title":"[Expert consensus on novel coronavirus pneumonia in Shandong]","volume":"60","author":"Dong","year":"2020","journal-title":"Shandong medicine"},{"issue":"1","key":"10.1016\/j.biopha.2020.110316_bib0030","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41392-020-0176-0","article-title":"Therapeutic efficacy of Pudilan Xiaoyan Oral Liquid (PDL) for COVID-19 in vitro and in vivo","volume":"5","author":"Deng","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"D1","key":"10.1016\/j.biopha.2020.110316_bib0035","doi-asserted-by":"crossref","first-page":"D1117","DOI":"10.1093\/nar\/gkx1028","article-title":"TCMID 2.0: a comprehensive resource for TCM","volume":"46","author":"Huang","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2020.110316_bib0040","doi-asserted-by":"crossref","first-page":"21146","DOI":"10.1038\/srep21146","article-title":"BATMAN-TCM: a bioinformatics analysis tool for molecular mechANism of traditional chinese medicine","volume":"6","author":"Liu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2020.110316_bib0045","doi-asserted-by":"crossref","first-page":"1.30.1","DOI":"10.1002\/cpbi.5","article-title":"The GeneCards suite: from gene data mining to disease genome sequence analyses","volume":"54","author":"Stelzer","year":"2016","journal-title":"Curr. Protoc. Bioinformatics"},{"issue":"D1","key":"10.1016\/j.biopha.2020.110316_bib0050","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"10.1016\/j.biopha.2020.110316_bib0055","doi-asserted-by":"crossref","first-page":"W199","DOI":"10.1093\/nar\/gkz401","article-title":"WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs","volume":"47","author":"Liao","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.biopha.2020.110316_bib0060","first-page":"D498","article-title":"The reactome pathway knowledgebase","volume":"48","author":"Jassal","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2020.110316_bib0065","first-page":"1","article-title":"[TCMATCOV--a bioinformatics platform to predict efficacy of TCM anti-COVID-19]","volume":"3","author":"Guo","year":"2020","journal-title":"China J. Chinese Matera Med."},{"key":"10.1016\/j.biopha.2020.110316_bib0070","first-page":"2020","article-title":"Clinical and immunological features of severe and moderate coronavirus disease","author":"Chen","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2020.110316_bib0075","doi-asserted-by":"crossref","first-page":"102452","DOI":"10.1016\/j.jaut.2020.102452","article-title":"Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?","author":"Liu","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.biopha.2020.110316_bib0080","doi-asserted-by":"crossref","first-page":"137799","DOI":"10.1172\/jci.insight.137799","article-title":"The laboratory tests and host immunity of COVID-19 patients with different severity of illness","author":"Wang","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.biopha.2020.110316_bib0085","first-page":"1","article-title":"Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection","author":"Kong","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2020.110316_bib0090","doi-asserted-by":"crossref","first-page":"104759","DOI":"10.1016\/j.antiviral.2020.104759","article-title":"A potential role for integrins in host cell entry by SARS-CoV-2","volume":"177","author":"Sigrist","year":"2020","journal-title":"Antiviral Res."},{"key":"10.1016\/j.biopha.2020.110316_bib0095","doi-asserted-by":"crossref","DOI":"10.1007\/s12015-020-09976-7","article-title":"CD147 as a target for COVID-19 treatment: suggested effects of azithromycin and stem cell engagement","author":"Ulrich","year":"2020","journal-title":"Stem Cell Rev Rep"},{"issue":"24","key":"10.1016\/j.biopha.2020.110316_bib0100","first-page":"5277","article-title":"[Expert consensus statement on Pudilan Xiaoyan Oral Liquid in clinical practice]","volume":"44","author":"Wang","year":"2019","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"10.1016\/j.biopha.2020.110316_bib0105","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jep.2017.07.009","article-title":"Pudilan xiaoyan oral liquid alleviates LPS-induced respiratory injury through decreasing nitroxidative stress and blocking TLR4 activation along with NF-KappaB phosphorylation in mice","volume":"214","author":"Feng","year":"2018","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2020.110316_bib0110","doi-asserted-by":"crossref","first-page":"109833","DOI":"10.1016\/j.biopha.2020.109833","article-title":"GC-MS based metabolomic profiling of lung tissue couple with network pharmacology revealed the possible protection mechanism of Pudilan Xiaoyan Oral Liquid in LPS-induced lung injury of mice","volume":"124","author":"Tian","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2020.110316_bib0115","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.intimp.2016.02.028","article-title":"Organic acid component from Taraxacum mongolicum Hand.-Mazz alleviates inflammatory injury in lipopolysaccharide-induced acute tracheobronchitis of ICR mice through TLR4\/NF-kappaB signaling pathway","volume":"34","author":"Yang","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2020.110316_bib0120","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jep.2016.09.013","article-title":"Corydalis bungeana Turcz. Attenuates LPS-induced inflammatory responses via the suppression of NF-kappaB signaling pathway in vitro and in vivo","volume":"194","author":"Zhai","year":"2016","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110316_bib0125","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.antiviral.2005.07.002","article-title":"Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds","volume":"68","author":"Lin","year":"2005","journal-title":"Antiviral Res."},{"key":"10.1016\/j.biopha.2020.110316_bib0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2020.1761883","article-title":"A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2","author":"Islam","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"1","key":"10.1016\/j.biopha.2020.110316_bib0135","doi-asserted-by":"crossref","first-page":"64","DOI":"10.5582\/bst.2020.01030","article-title":"Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment","volume":"14","author":"Wang","year":"2020","journal-title":"Biosci. Trends"},{"issue":"3","key":"10.1016\/j.biopha.2020.110316_bib0140","doi-asserted-by":"crossref","DOI":"10.3390\/diseases4030026","article-title":"Human coronaviruses: a review of virus-host interactions","volume":"4","author":"Lim","year":"2016","journal-title":"Diseases"},{"issue":"6","key":"10.1016\/j.biopha.2020.110316_bib0145","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3390\/v4060980","article-title":"Recent progress in studies of arterivirus- and coronavirus-host interactions","volume":"4","author":"Zhong","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.biopha.2020.110316_bib0150","first-page":"104761","article-title":"Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)","author":"Li","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2020.110316_bib0155","series-title":"Expert Consensus on Novel Coronavirus Pneumonia in Children in Hunan","author":"Committee","year":"2020"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220305084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220305084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T02:41:54Z","timestamp":1777689714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220305084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":31,"alternative-id":["S0753332220305084"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110316","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of the molecular mechanism of Pudilan (PDL) treatment for COVID-19 by network pharmacology tools","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110316","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"110316"}}